A Japanese company has chosen Aagami to partner with marketing and selling companies from the US, India and across the world for their on the market p...
Published : 02 Jun 2020
Read MoreAagami has received an assignment from a French company developing a natural tobacco leaf extracted drug for smoking cessation. Only 2 injections for ...
Published : 19 May 2020
Read MoreWe all know that Covid-19 has taken a toll on humanity, spreading across almost all countries, infecting more than 225,000 people globally, and taking...
Published : 19 Mar 2020
Read MoreAagami has secured an innovative startup client to support their investment and partnering initiatives. Aagami’s extensive knowledge and networ...
Published : 09 Mar 2020
Read MoreAn Israeli client, has given a new assignment to Aagami, for partnering their Drug-device combination to prevent Hangover and Asian Flush based on FDA...
Published : 06 Jan 2020
Read MoreAagami is proud to announce that it will be representing multiple clients with respect to the partnering of their assets and technologies, during JPM ...
Published : 09 Dec 2019
Read MoreAagami has now increased its focus in IP monetization and offers integrated IP Research/ Licensing/Sale solutions to global clientele. For this i...
Published : 04 Nov 2019
Read MoreAagami is participating in JP Morgan Healthcare conference and Biotech Showcase January 2020 (13-16 January 2020 in San Francisco, CA). Both even...
Published : 02 Oct 2019
Read MoreAagami has been appointed by a new client to help out-license their on the market drug as well as other assets/ technologies in their extensive pipeli...
Published : 12 Sep 2019
Read MoreHappy Customers keep coming back. An Aagami client who gave us several assignments earlier has now engaged Aagami again for supporting his new startup...
Published : 26 Aug 2019
Read More